Aehr Test Systems

Aehr Test Systems Q1 2027 Earnings Recap

AEHR Q1 2027 Published November 4, 2026

Get alerts when AEHR reports next quarter

Set up alerts — free

Aehr Test shares rose 26.5% after the company raised its fiscal 2027 revenue outlook to $150 million, the top of its previous range, following record first-quarter revenue and strong bookings. The main caveat is that NAND opportunities are progressing more slowly than expected, while a major AI customer’s potential high-volume production decision remains contingent on evaluation.

Earnings Per Share Beat
$0.22 vs $0.11 est.
+100.0% surprise
Revenue Beat
33007000 vs 27533000 est.
+19.9% surprise

Market Reaction

Post-Earnings +26.50%

See AEHR alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Fiscal Q1 revenue was a record $33.0 million, up 200% year over year and 75% sequentially; non-GAAP net income was $9.4 million.
  • Bookings were $46.7 million, a 1.4 book-to-bill; effective backlog, including post-quarter bookings, was $109.3 million as of November 1.
  • Aehr raised fiscal 2027 revenue guidance to $150 million from a prior range of $130 million to $150 million, and expects full-year non-GAAP net income of at least 20% of revenue.
  • A major AI accelerator supplier plans to install an evaluated wafer-level burn-in test cell in early calendar 2027; a high-volume production decision is expected only after installation and validation.
  • NAND flash opportunities are advancing more slowly than expected, reflecting limited incremental manufacturing capacity and the timing of new high-bandwidth flash volumes.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit AEHR on AllInvestView.

Get the Full Picture on AEHR

Track Aehr Test Systems in your portfolio with real-time analytics, dividend tracking, and more.

View AEHR Analysis